18f-fdg
Showing 1 - 25 of 29
18F-FAPI, 18F-FDG, Pancreas Adenocarcinoma Trial in Hangzhou (18F-FAPI, 18F-FDG)
Completed
- 18F-FAPI
- +4 more
- 18F-FAPI
- 18F-FDG
-
Hangzhou, Zhejiang, Chinathe First Affiliated Hospital, School of Medicine, Zhejiang Univ
May 31, 2023
GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)
Enrolling by invitation
- GEP-NET
- +3 more
- 18F-FDG
- 64Cu-Dotatate
-
Copenhagen, DenmarkRigshospitalet
Jan 24, 2023
Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, Injection of hyperpolarized
Enrolling by invitation
- Breast Cancer
- +3 more
- 18F-FDG
- +2 more
-
Copenhagen, DenmarkRigshospitalet
Jan 18, 2023
Multiple Myeloma Trial in Shenyang (18F-PSMA-1007, 18F-FDG)
Recruiting
- Multiple Myeloma
- 18F-PSMA-1007
- 18F-FDG
-
Shenyang, Liaoning, ChinaThe First Affiliated Hospital of China Medical University
Jul 6, 2022
Healthy Subjects, Cardiovascular Disease Trial (18F-FDG, 11C-butanol)
Not yet recruiting
- Healthy Subjects
- Cardiovascular Disease
- 18F-FDG
- 11C-butanol
- (no location specified)
Aug 22, 2023
Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-P16-093, 18F-FDG)
Recruiting
- Clear Cell Renal Cell Carcinoma
- 68Ga-P16-093
- 18F-FDG
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 21, 2022
Rectal Cancer Trial in Wuhan (68Ga-FAPI-04, 18F-FDG)
Recruiting
- Rectal Cancer
- 68Ga-FAPI-04
- 18F-FDG
-
Wuhan, Hubei, ChinaChina, Hubei Province
Aug 11, 2023
Tumor of Lung Trial in Beijing (drug, device, procedure)
Not yet recruiting
- Neoplasm of Lung
- 18F-FDG
- +2 more
-
Beijing, Beijing, ChinaPeking University First Hospital
Apr 21, 2023
Lung Tumors Trial in Beijing (68Ga-FAPI-RGD, 18F-FDG, 68Ga-FAPI)
Recruiting
- Lung Neoplasms
- 68Ga-FAPI-RGD
- +3 more
-
Beijing, ChinaPeking Union Medical College Hospital
Sep 13, 2022
Lung Cancer, Colorectal Cancer Trial in Beijing (18F-FDG)
Recruiting
- Lung Cancer
- Colorectal Cancer
- 18F-FDG
-
Beijing, ChinaBeijing Cancer Hospital
Mar 27, 2023
Prostate Tumors, Prostatic Cancer, Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, 18F-FDG,
Enrolling by invitation
- Prostate Neoplasms
- +4 more
- 18F-DCFPyL
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Pulmonary Fibrosis Trial in Beijing (68Ga-FAPI, 18F-FDG)
Not yet recruiting
- Pulmonary Fibrosis
- 68Ga-FAPI
- 18F-FDG
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 4, 2021
Breast Cancer, Prostate Cancer, Brain Tumor Trial in Beijing (68Ga-RM26-RGD, 18F-FDG, 68Ga-RM26)
Recruiting
- Breast Cancer
- +3 more
- 68Ga-RM26-RGD
- +3 more
-
Beijing, ChinaPeking Union Medical College Hospital
Sep 18, 2022
Solid Tumor Trial (18F-FDG)
Not yet recruiting
- Solid Tumor
- 18F-FDG
- (no location specified)
Jul 18, 2022
Solid Tumor Trial in Beijing (18F-FDG)
Recruiting
- Solid Tumor
- 18F-FDG
-
Beijing, Beijing, ChinaBeijing cancer hospital
Jun 23, 2022
Urothelial Carcinoma Trial in Beijing (18F-FDG)
Recruiting
- Urothelial Carcinoma
- 18F-FDG
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jul 18, 2022
Lung Cancer Trial in Groningen (18F-FDG, PET/CT imaging)
Recruiting
- Lung Cancer
- 18F-FDG
- PET/CT imaging
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jul 14, 2022
Uterine Cervical Tumors Trial in Toronto (Hyperpolarized 13C-Pyruvate, 18F-FDG)
Terminated
- Uterine Cervical Neoplasms
- Hyperpolarized 13C-Pyruvate
- 18F-FDG
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Sep 20, 2022
Type 1 Diabetes Trial in New York (Evolocumab Cartridge, Atorvastatin Calcium Tablets, Ezetimibe Tablets)
Recruiting
- Type 1 Diabetes
- Evolocumab Cartridge
- +6 more
-
New York, New York
- +2 more
Nov 29, 2022
Peripheral Arterial Disease, Claudication, Intermittent, Claudication Trial in San Francisco (18F-FDG)
Completed
- Peripheral Arterial Disease
- +6 more
- 18F-FDG
-
San Francisco, California
- +1 more
Nov 25, 2020
Breast Cancer Trial in Saint Louis (18F-FFNP, CTI/Siemens Biograph 40 PET/CT Scanner, Estradiol)
Completed
- Breast Cancer
- 18F-FFNP
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 13, 2020
B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)
Completed
- B-Cell Neoplasm
- +15 more
- 18F-FSPG
- 18F-FDG
-
Stanford, CaliforniaStanford University Medical Center
Dec 11, 2018
Cardiac Sarcoidosis Trial in Edinburgh (18F-FDG, Prednisolone)
Unknown status
- Cardiac Sarcoidosis
- 18F-FDG
- Prednisolone
-
Edinburgh, Midlothian, United KingdomQueen's Medical Research Institute
Oct 12, 2018